United-Guardian, Inc. (UG)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

16.54

+0.33

(+2.03%)

As of 02:42PM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Engulfing Line (Bearish)

View all chart patterns

Performance Outlook

Previous Close	16.21
Open	15.63
Bid	15.96 x 1000
Ask	16.65 x 1400
Day's Range	15.63 - 16.73
52 Week Range	13.40 - 26.09
Volume	10,191
Avg. Volume	11,027

Market Cap	75.985M
Beta (5Y Monthly)	0.30
PE Ratio (TTM)	17.41
EPS (TTM)	0.95
Earnings Date	Nov 08, 2022 - Nov 14, 2022
Forward Dividend & Yield	1.02 (6.43%)
Ex-Dividend Date	May 20, 2022
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-7% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for UG

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

United-Guardian, Inc.
Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
Rating
Fair Value
Economic Moat
3 days agoMorningstar

All

Simply Wall St.
Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
It is hard to get excited after looking at United-Guardian's (NASDAQ:UG) recent performance, when its stock has...
- Are Robust Financials Driving The Recent Rally In Badger Meter, Inc.'s (NYSE:BMI) Stock?
  Simply Wall St.
- Why DATA Communications Management Corp. (TSE:DCM) Looks Like A Quality Company
  Simply Wall St.
Simply Wall St.
Investors in United-Guardian (NASDAQ:UG) have unfortunately lost 13% over the last three years
As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...
GlobeNewswire
United-Guardian Completes Review of Strategic Alternatives; Announces Retirement of the Company’s CEO
HAUPPAUGE, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that it has completed the formal review of strategic alternatives that it initiated in January, and concluded that there were no opportunities presented to the company that the Board of Directors believed would be in the best interests of the company to pursue at the present time. While the active efforts that began in January will be suspended, the company will continue to explore opportunities